Reuters01-14
** Shares of Recce Pharmaceuticals RCE.AX rise 3% to A$0.69, their highest level since early Sept 2023
** Pharmaceutical co receives cash refund of A$5.3 million ($3.55 million) research and development tax incentive rebate from the Australian Taxation Office
** Stock up 35.3% in 2025
($1 = 1.4932 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((Jasmeenaraislam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
